By using ML models to classify patients with SPS and anti-GAD65 controls, our methodology allowed us to determine clinical features that may be linked with the diagnosis of SPS: depression, hypothyroidism, GERD, and joint pain. This evidence concerns the gene GAD2 and hypothyroidism.